ABSTRACT: Background. Racial outcome disparities have been observed in head and neck squamous cell carcinoma (HNSCC) with diminished survival for black patients compared with white patients. Methods. We retrospectively analyzed 1318 patients with primary HNSCC treated at the University of Maryland Greenebaum Cancer Center (UMGCC) from 2000 to 2010. Results. Of all the patients, 65.9% were white, 30.7% were black, and 3.3% were of other races. Black patients were less likely to present with oral cavity cancer, and more likely to present with laryngeal or hypopharyngeal cancers. White patients were more likely to have early stage disease, especially in the oral cavity. Black race was independently associated with worse overall survival (OS) in the entire cohort. Black patients had a significantly worse OS among oral cavity and oropharyngeal cancers, with the largest disparity in oropharyngeal cancer. However, in multivariate analysis, race was only still significant in oropharyngeal cancer. Conclusion. We observed differences by race in distribution of disease site, stage, and OS. Survival disparity in the entire cohort was driven mostly by differences among oropharyngeal cancer.
INTRODUCTION
Head and neck squamous cell carcinoma (HNSCC) includes cancers that originate in the oral cavity, oropharynx, hypopharynx, and larynx. Worldwide, HNSCC is the sixth most common cancer, 1 and it estimated that, in 2013, there will be a total of 53,640 new cases of oral cavity, laryngeal, and pharyngeal cancer diagnosed in the United States. 2 Traditional risk factors for HNSCC include smoking and alcohol; however, additional research over the last 3 decades has shown that the human papillomavirus (HPV) has an etiological role in the development of oropharyngeal squamous cell carcinoma (OPSCC), with predilection for tumors involving the tonsils or base of tongue. 3, 4 Importantly, HPVpositive oropharyngeal cancers are more responsive to treatment with improved survival. [5] [6] [7] [8] Race-based differences in disease characteristics, referral patterns, treatments, and outcomes are observed in a number of malignancies, including prostate cancer, 9, 10 breast cancer, 11, 12 and acute myeloid leukemia. [13] [14] [15] Disparities between black and white patients are also seen in HNSCC. Compared with white patients, black patients have a higher incidence rate of HNSCC, 16, 17 and are diagnosed at a younger age. [18] [19] [20] They are more likely to have a history of tobacco and alcohol exposure, 21, 22 present at a more advanced stage of disease, 20, 22, 23 and are more likely to undergo nonoperative treatment. 23, 24 Worse outcomes, including disease-specific survival and overall survival (OS), are seen in black patients even after controlling for baseline characteristics, including stage and treatment. [25] [26] [27] Additionally, recent analysis pioneered by studies from our group demonstrate remarkable disparities in the prevalence of HPV-positive OPSCC between black patients and white patients. [28] [29] [30] [31] The higher prevalence of HPV-positive OPSCC in white patients and the associated improved prognosis may partially explain overall differences in survival by race. 29, 32 Most of the analysis on racial disparities in HNSCC comes from tumor registries spanning multiple centers. Therefore, we retrospectively analyzed patients with 
MATERIALS AND METHODS
After institutional review board approval, we performed a retrospective medical chart review of data from patients treated at UMGCC for HNSCC from 2000 to 2010. We identified cases with biopsy proven squamous cell carcinoma of the oropharynx, oral cavity, larynx, or hypopharynx treated for a first primary diagnosis. Data collected included race, sex, age at diagnosis, smoking status, alcohol use, tumor stage, nodal stage, overall staging, treatment received, and year of diagnosis. Race as well as tobacco smoking and alcohol status of patients was self-reported. TNM staging (www.nccn.org) was used to define tumor, nodal, and overall staging. Any missing values were recorded as unknown.
Statistical consideration
This retrospective statistical analysis was conducted using records on the 1318 patients treated at UMGCC. Patients' demographic and clinical on-study characteristics were summarized and compared between 2 ethnic groups (ie, black patients and white patients), for the entire cohort and within a cancer site. The Fisher's and Fisher-Freeman-Halton tests for categorical variables and the general linear models approach for continuous variables were utilized. Corresponding to these tests, probabilities were either 2-sided exact or calculated with the use of Monte-Carlo simulations.
1 OS was defined from the date of diagnosis until the date of death from any cause or censored at the date last known alive. OS functions were estimated and compared using the Kaplan-Meier approach and the log-rank tests, respectively. Median OS times with the corresponding 95% confidence intervals (CIs) were calculated. The univariable and multivariable Cox regression models were applied to identify plausible predictors as well as the magnitude of their effect on survival parameters (hazard ratio [HR] , hazard of death). All statistical tests were done at 0.05 type I error. Statistical analyses were conducted using S-plus version 8.2 (TIBCO) and SAS version 9.3 (SAS Institute, Cary, NC).
RESULTS
A total of 1318 patients with first primary oral cavity, oropharyngeal, laryngeal, or hypopharyngeal tumors treated at UMGCC were identified between 2000 and 2010. Racial distribution included 65.9% (869) white patients, 30.7% (405) black patients, and 3.3% (44) patients from other races. The median age of the entire population was 60 years, and patients were predominantly men (72.7%). Breakdown by anatomic site included 43.2% (570) oral cavity, 28.3% (373) oropharynx, 23.6% (311) larynx, and 4.9% (64) hypopharynx (Table 1) .
Compared to all white patients, black patients differed in sex distribution with a higher percentage of men (76.5%), and were more likely to have a history of smoking or alcohol or combined smoking and alcohol. White patients and black patients differed significantly in TNM staging at presentation and treatments received, with black patients having a higher percentage of locally advanced disease (stage III/IVa/IVb) and being treated with chemoradiation or radiation alone versus the majority of white patients who were treated with surgery (Table  2) . By primary site, there was a significant difference in treatment between black patients and white patients with oral cavity, oropharynx, and hypopharyngeal cancers, but not for patients with cancers of the larynx (Supplementary  Table 1 , online only). Ninety-six percent of patients with oral cavity cancer underwent surgery accounting for the largest number of patients treated with surgical resection, and the largest disparity in surgical treatment in which 77% of white patients and 61% of black patients with oral cavity were treated with surgery alone.
There were also significant differences in racial distribution between primary sites (Table 3) . Although black patients made up 30.7% of our HNSCC population overall, they accounted for 65.6% of hypopharyngeal, 47.9% of laryngeal, and 33.5% of oropharyngeal cancers. The largest disparity between races was in oral cavity cancers in which black patients accounted for 15.6% of patients while white patients accounted for 79.3%. Smoking and alcohol status as well as stage differed significantly between primary site with the largest percentage of smokers in laryngeal primaries and both alcohol users and smokers among cancers in the hypopharynx. The greatest proportion of early-stage (stage I and II) diagnosis was among patients with oral cavity tumors, with the largest percentage of locally advanced cases among oropharyngeal and hypopharyngeal cancers. Survival analysis (Table 4 , Figures 1 and 2 ) for our entire population showed a significantly worse OS for all black patients compared to white patients (median, 2.5 years vs 4.8 years, respectively; p < .0001; see Figure 1 ). By primary site, black patients had a significantly worse OS compared to white patients for both oropharyngeal (median, 4.9 vs 2.1 years, respectively; p < .0001; Figure   2A ) and oral cavity tumors (median, 5.7 vs 3.2 years, respectively; p < .0001; Figure 2B ). There was no difference in OS between black patients and white patients for both laryngeal and hypopharyngeal cancers ( Figure 2C and 2D, respectively).
In order to evaluate the effect of relevant baseline characteristics, including race, age, sex, smoking and alcohol status, and stage on OS, we conducted a multivariable regression analysis for the entire cohort of patients with HNSCC as well as by individual primary site. For all patients, OS was independently affected by all of these characteristics (as well as primary site) except for sex, with the hazard of death in black patients 1.2 times that of white patients (Table 5 ). Although black patients had worse survival than white patients with cancer in the oral cavity, in multivariable Cox regression model, race no longer had a significant effect on survival (Supplementary  Table 2 , online only). However, among patients with oropharyngeal cancer, race was still strongly associated with worse outcome with black patients having a risk of death 1.6 times that of white patients even after controlling for sex, age, smoking and alcohol, and stage (Table 6 ). Among patients with laryngeal cancer, OS survival was effected by age and stage of disease (Supplementary  Table 3 , online only), whereas among patients with hypopharyngeal cancer, no risk factors associated with OS were identified (Supplementary Table 4 , online only).
DISCUSSION
In our retrospective analysis of 1318 patients with HNSCC treated at UMGCC from 2000 to 2010, we found that black patients had a significantly worse OS than white patients, including after controlling for age, sex, tobacco and alcohol use, stage, and primary site. By primary site, black patients with oral cavity and oropharyngeal cancers fared worse than white patients. However, after including the aforementioned baseline characteristics in a multivariate model, black race was associated with worse outcome only among oropharyngeal primaries.
In analysis of our entire patient population, black patients were younger, had a higher male predominance, were more likely to use tobacco and alcohol, and present at a more advanced stage compared to white patients. These findings are similar to what has been reported in the literature. [18] [19] [20] [21] [22] For example, analysis of 1128 patients with HNSCC using a tumor registry in the southern United States, showed that a significantly higher percentage of black patients were diagnosed before the age of 50 years (33.9% vs 25.1%, respectively). 20 Reasons for black patients presenting at a younger age are unclear but may have to do with smoking and drinking patterns, both of which are significant risk factors for HNSCC. 18, 33 Black patients have repeatedly been observed to present at a more advanced stage then white patients. 20, [34] [35] [36] Although reasons for presentation at a later stage are complex, including various socioeconomic factors, data from a cohort study involving patients with oral cavity and laryngeal cancers treated at the University of Pittsburgh found that black patients presented at a more advanced stage even after matching for smoking and age, and adjusting for socioeconomic status and insurance. 35 In our univariate survival analysis by primary site, black patients with both oral cavity and oropharyngeal tumors had a significantly inferior OS compared with white patients with a greater disparity in outcome among the oropharynx. Multivariate analysis showed that, after controlling for sex, age, stage and tobacco and alcohol, black race was associated with worse outcome among patients with oropharyngeal cancer, whereas it was not a significant predictor of outcome for patients with oral cavity tumors. No difference in survival by race was seen among patients with laryngeal or hypopharyngeal cancer.
In our institutional experience, we observed striking differences in the racial and sex distribution of patients by disease site. The largest disparity between numbers of black patients and white patients occurred in the oral cavity in which patients were predominantly white. Although by Surveillance, Epidemiology, and End Results (SEER) data, reported age-adjusted incidence rates per 100,000 patients from 2006 to 2010 showed a higher age-adjusted incidence for white patients compared to black patients among cancers of the tongue (3.4 vs 2.2, respectively) and lip (0.8 vs 0.1, respectively) there were no differences at all other sites in the oral cavity (www.seer.cancer.gov). By sex, the oral cavity had the highest percentage of female patients (30%) with a striking difference by race, where 80% of women were white and only 15% were black. In no other primary site was there such a large disparity in racial distribution of female patients. Indeed, in analysis of SEER data over the past 4 decades, the incidence of oral cavity cancers have been increasing in younger women over time. This increase has been driven specifically by an increasing incidence of oral tongue cancers in white women, whereas the incidence has been decreasing in black women. 37, 38 For example, although the overall incidence of oral tongue cancer decreased by 4% between 1975 and 2007, with a 55% decrease in black women, the incidence increased by 21% in all white women, with a striking 111% increase in younger white women ages 18 to 44 years. 38 The reason for a rise in incidence of oral cavity cancers among white women is unclear and requires further investigation.
In our population, oral cavity tumors had the highest percentage of patients diagnosed with local disease (stage I and II). Additionally, the largest disparity in treatment with surgery alone was in the oral cavity, likely driven by earlier stage presentation in white patients. Other studies have also shown that, for cancers of the oral cavity, black patients present in a later stage. Analysis of SEER data from 1973 to 2002, including 46,855 cases of oral cavity cancers, found that black patients were significantly more likely to present with more advanced stage. 36 Disparity in stage at diagnosis for oral cavity tumors may partially be explained by disparities in dental care. Patients referred to oral maxillofacial surgeons from a dentist's office had a significantly earlier stage of disease compared with those referred from a medical office, 39 with numerous studies finding a lower access to routine dental care among blacks compared to whites. 40, 41 With surgery being the predominant treatment of oral cavity cancers, the disparity in surgical treatment in our population was likely driven by the increased prevalence of early stage oral cavity cancers in white patients.
Compared to the oral cavity, our patients with oropharyngeal cancer were more homogenous, being 82% men, with 90.1% having locally advanced disease (stage III, IVa, IVb). Treatment was primarily with chemoradiation for both races with a slightly higher number of surgically treated white patients as a result of an earlier stage at presentation driving the difference in treatment distribution for this primary site. Black patients had a significantly worse OS in univariate analysis with the largest disparity in outcome by race among patients with oropharyngeal cancer. Race was still associated with worse survival after controlling for other baseline characteristics. Although we do not have data on HPV status on the full cohort in this study, based on our previous analysis, 42 we hypothesize that the significantly higher prevalence of favorable prognosis of HPV-positive white patients with oropharyngeal cancer may account for the observed disparity in survival in this study. Our group, as well as others, have consistently observed a significantly higher prevalence of HPV-positive OPSCC among white patients compared with black patients. [28] [29] [30] [31] Recently, we analyzed 200 patients with oropharyngeal cancer treated at UMGCC from 1992 to 2007, with tissue available for HPV16 testing, finding that white race was associated with a significantly higher prevalence of HPV-positive OPSCC, including during each 4-year interval between 1992 and 2007. 42 Given the magnitude of improved survival in HPV-positive versus HPV-negative patients, improved outcome in white patients compared with black patients in our oropharyngeal cancer subset may, in part, result from a higher prevalence of HPV-positive cancers in our white patients.
Black patients accounted for a higher percentage of laryngeal and hypopharyngeal cancers compared with other primary sites. Increased prevalence of tobacco and alcohol consumption in our black patients may account for this, as alcohol and tobacco make up the primary risk factors for tumors at these anatomic locations. This is corroborated by SEER data reporting of age-adjusted incidence rates per 100,000 patients from 2006 to 2010, which showed a higher age-adjusted incidence of both laryngeal (5 vs 3.6) and hypopharyngeal cancers (1 vs 0.6) in black patients compared to white patients, respectively (www.seer.cancer.gov). OS for our patients with hypopharyngeal cancer was lower than for the other sites, similar to reports in the literature. 43 We found no difference in OS between black patients and white patients for both laryngeal and hypopharyngeal cancers. This is in contrast to most reports where black patients fared worse for these primary sites. 35, 44, 45 However, similar to our findings, analysis of 205 patients treated for laryngeal cancer at the Michael E. DeBakey Veterans Affairs Medical center found no difference in OS between black patients and white patient, with the authors suggesting that lack of an effect of ethnicity on outcome stemmed from a uniform approach to care of a homogenous population. 46 Similar to the experience of other groups, 27 ,34 among our entire cohort of patients, black patients had a significantly worse OS, including after controlling for other factors. Importantly, the overall disparity was driven largely by a more than 2-fold median survival difference in the subset of patients with oropharyngeal cancer. The inferior survival seen in oral cavity cancers was driven by a large number of white patients referred by dentists who were seen with stage I or II disease.
Although this suggests that biological differences between black patients and white patients with HNSCC may be contributing to the difference in outcome, our retrospective analysis cannot define the cause. Additionally, reasons for disparities in outcomes between races also involve the interplay of patient compliance and attitude toward care, comorbidity, and other socioeconomic factors. Our study lacks data on comorbidity and compliance with treatment, both of which can affect outcomes. 47 However, in our previous analysis of 202 patients with locally advanced HNSCC (oral cavity, oropharynx, larynx, hypopharynx) treated with chemoradiation at our institution between 1996 and 2006, 97% of patients completed all therapy with no difference in completion of treatment between black patients and white patients. 26 These patients represent a subset of the larger group in this report. Additionally, we were unable to quantitatively assess socioeconomic factors, such as insurance status, which has also been shown to effect outcomes in HNSCC. 20 Given that care of our patients with HNSCC at UMGCC is done in a multidisciplinary fashion with consistent treatment recommendations based on stage at presentation and primary site, treatment was not included in the multivariate model to avoid overlap in variables.
Our retrospective analysis describes the experience of a single institution with a large volume and diverse group of patients with HNSCC. Our analysis highlights the poor survival seen in both white patients and black patients with hypopharyngeal cancer, and corroborates multiple other reports, where black patients have been found to have worse survival even after controlling for various other factors, including smoking status and stage. Although reasons for disparities in survival by race in HNSCC are complex, continued analysis should be undertaken in order to improve outcomes for all patients. 
